Evidence map›Paper›PMID 29365322›Full record

ArticleBlood advances2018

Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis.

Neethu Menon, Ravi Sarode, Ayesha Zia

Open access · goldAbstract readCase Reports
In one paragraph

Article in Blood advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Inherited Thrombophilia in the Era of Direct Oral Anticoagulants.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Neethu MenonDivision of Hematology/Oncology, Department of Pediatrics, and.
Ravi SarodeDepartment of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX.
Ayesha ZiaDivision of Hematology/Oncology, Department of Pediatrics, and.ORCID 0000-0003-3283-0415
The University of Texas Southwestern Medical Center · US

Funding

Predicting and Preventing Poor Outcomes of Venous Thromboembolism in ChildrenK23HL132054 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI ZIA, AYESHA · 2016 to 2020
$876k
NHLBI NIH HHS K23 HL132054
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentFemaleHumansNecrosisProtein CProtein C DeficiencyRivaroxabanSecondary PreventionSkin DiseasesThrombinThrombomodulinWarfarinProtein CRivaroxabanThrombinThrombomodulinWarfarin

Identifiers

PMID29365322
PMCPMC5787863
OpenAlexW2783888372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.